South Africa: Operational Impacts and Strategy

The COVID-19 pandemic brought with it something of an IP truce, with major pharmaceutical companies seemingly happy to co-exist.

Participating countries attending the 12th Ministerial Conference of the World Trade Organization (WTO) in Geneva, Switzerland reached an agreement on 17 June 2022 to partially waive intellectual property restrictions on the manufacture and production of COVID-19 vaccines for the next five years.

We don't get to discuss know-how much in our articles. Yet it is, of course, something that falls squarely within the domain of intellectual property law because know-how is often protected by patents.

It seems like an eternity ago since the World Health Organisation declared a pandemic on 11 March 2020. Governments around the world have responded to the pandemic in different ways...

The COVID-19 pandemic has caused an unprecedented level of disruption to the hotel industry. As a result of the local lockdowns and travel restrictions many hotels have been forced to close...

Mandatory vaccinations in the workplace

The government's recent announcement of its plan to roll-out the Coronavirus (COVID-19) vaccine nationwide has triggered many questions and concerns, highlighting a collision of seemingly...

"Inventa IP Review" is an annual compilation with the main Intellectual Property (IP) topics that occurred in the previous year.

President Biden issued a presidential proclamation that bans entry into the U.S. for travelers who were physically present in Brazil, Ireland, the UK,